Results
Differentially Expressed miRNAs List
| miRNA ID | Source ID | Cancer Type | Cancer Subtype | Cell Line | Design | logFC | Expression Status | Experiment ID |
|---|---|---|---|---|---|---|---|---|
| hsa-miR-219a-2-3p | TCGA_KIRC | kidney cancer | kidney cancer | N/A | high grade vs low grade | -0.16 | DOWN | EXP00364 |
| hsa-miR-219a-2-3p | TCGA_KIRC | kidney cancer | kidney cancer | N/A | high grade vs low grade | -0.19 | DOWN | EXP00365 |
| hsa-miR-219a-2-3p | TCGA_KICH | kidney cancer | kidney cancer | N/A | high grade vs low grade | 0.63 | UP | EXP00372 |
| hsa-miR-219a-2-3p | TCGA_KICH | kidney cancer | kidney cancer | N/A | high grade vs low grade | 0.70 | UP | EXP00373 |
| hsa-miR-219a-2-3p | TCGA_COAD | colon cancer | colon cancer | N/A | cancer vs normal | -0.28 | DOWN | EXP00387 |
| hsa-miR-219a-2-3p | TCGA_THCA | thyroid cancer | thyroid cancer | N/A | cancer vs normal | -1.19 | DOWN | EXP00396 |
| hsa-miR-219a-2-3p | TCGA_LIHC | hepatocellular carcinoma | hepatocellular carcinoma | N/A | cancer vs normal | 0.55 | UP | EXP00409 |
| hsa-miR-219a-2-3p | GSE69127 | larynx cancer | larynx cancer | N/A | subtype1 vs subtype2 | -4.18 | DOWN | EXP00462 |
| hsa-miR-219a-2-3p | GSE106817 | breast cancer | breast cancer | N/A | blood | 1.04 | UP | EXP00521 |
| hsa-miR-219a-2-3p | GSE106817 | pancreatic cancer | pancreatic cancer | N/A | blood | 0.63 | UP | EXP00529 |
| hsa-miR-219a-2-3p | GSE113486 | breast cancer | breast cancer | N/A | blood | 0.98 | UP | EXP00530 |
| hsa-miR-219a-2-3p | GSE113486 | colorectal cancer | colorectal cancer | N/A | blood | 1.52 | UP | EXP00531 |
| hsa-miR-219a-2-3p | GSE113486 | bladder cancer | bladder cancer | N/A | blood | 0.62 | UP | EXP00541 |
| hsa-miR-219a-2-3p | GSE113740 | breast cancer | breast cancer | N/A | blood | 1.24 | UP | EXP00601 |
| hsa-miR-219a-2-3p | GSE113740 | colorectal cancer | colorectal cancer | N/A | blood | 1.32 | UP | EXP00602 |